BEYOND AIR INC. - COMMON STOCK

Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer

01 Dec 2021 07:00:02 By Nasdaq GlobeNewswire

Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement

18 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022

11 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Formation of Beyond Cancer™, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors

04 Nov 2021 06:30:00 By Nasdaq GlobeNewswire

Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

02 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast

25 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease

20 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® Provides Global Regulatory Update for LungFit® PH

21 Sep 2021 15:30:00 By Nasdaq GlobeNewswire

Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

14 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Beyond Air® Announces CFO Transition

20 Aug 2021 15:15:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022

10 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast

20 Jul 2021 06:30:00 By Nasdaq GlobeNewswire

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021

08 Jul 2021 15:14:49 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2021

10 Jun 2021 15:05:00 By Nasdaq GlobeNewswire

Beyond Air® Reaches Settlement Agreement with Circassia for LungFit® PH

26 May 2021 06:30:00 By Nasdaq GlobeNewswire

Beyond Air® Schedules Fiscal Year 2021 Financial Results Conference Call and Webcast

25 May 2021 06:30:00 By Nasdaq GlobeNewswire

Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing

20 May 2021 07:00:02 By Nasdaq GlobeNewswire

Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021

13 May 2021 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® Appoints Peter Senior as Director of Business Development

03 May 2021 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021

14 Apr 2021 07:00:01 By Nasdaq GlobeNewswire